Earnings Feed
Start Free
Home/Filings/4/0001796960-26-000002
4//SEC Filing

Flammer Martina M.D. 4

Accession 0001796960-26-000002

CIK 0001104506other
View on SEC.govCompany Profile

Filed

Jan 5, 7:00 PM ET

Accepted

Jan 6, 4:06 PM ET

Size

28.7 KB

Accession

0001796960-26-000002

Insider Transaction Report

Form 4
Period: 2026-01-02
INSMED IncINSM
Flammer Martina M.D.
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2026-01-02+5,998→ 89,109 total
  • Award

    Common Stock

    2026-01-02+5,645→ 94,754 total
  • Exercise/Conversion

    Common Stock

    2026-01-05$19.74/sh+4,358$86,027→ 99,112 total
  • Exercise/Conversion

    Common Stock

    2026-01-05$29.13/sh+7,945$231,438→ 107,057 total
  • Sale

    Common Stock

    2026-01-05$169.29/sh−2,799$473,843→ 104,258 total
  • Sale

    Common Stock

    2026-01-05$170.61/sh−3,205$546,805→ 101,053 total
  • Sale

    Common Stock

    2026-01-05$171.19/sh−2,836$485,495→ 98,217 total
  • Sale

    Common Stock

    2026-01-05$171.92/sh−286$49,169→ 97,931 total
  • Sale

    Common Stock

    2026-01-05$173.45/sh−1,820$315,679→ 96,111 total
  • Sale

    Common Stock

    2026-01-05$174.28/sh−655$114,153→ 95,456 total
  • Sale

    Common Stock

    2026-01-05$175.73/sh−702$123,362→ 94,754 total
  • Award

    Stock Option (right to buy)

    2026-01-02+31,280→ 31,280 total
    Exercise: $177.12Exp: 2036-01-02→ Common Stock (31,280 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2026-01-05−4,358→ 8,715 total
    Exercise: $19.74Exp: 2033-01-05→ Common Stock (4,358 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2026-01-05−7,945→ 31,780 total
    Exercise: $29.13Exp: 2034-01-04→ Common Stock (7,945 underlying)
Footnotes (12)
  • [F1]Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested.
  • [F10]This is the weighted average sales price representing 702 shares sold at prices ranging from $175.54 to $176.12 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  • [F11]These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter until fully vested.
  • [F12]The options become exercisable based on the following vesting schedule: 25% vest on the first anniversary of the grant date and an additional 12.5% vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.
  • [F2]Each RSU was granted on January 2, 2026 for no consideration.
  • [F3]Represents RSUs, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest in full on February 1, 2029.
  • [F4]This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
  • [F5]This is the weighted average sales price representing 2,799 shares sold at prices ranging from $168.88 to $169.69 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  • [F6]This is the weighted average sales price representing 3,205 shares sold at prices ranging from $169.91 to $170.90 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  • [F7]This is the weighted average sales price representing 2,836 shares sold at prices ranging from $170.91 to $171.89 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  • [F8]This is the weighted average sales price representing 1,820 shares sold at prices ranging from $173.05 to $173.87 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  • [F9]This is the weighted average sales price representing 655 shares sold at prices ranging from $174.20 to $174.43 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Documents

1 file

Issuer

INSMED Inc

CIK 0001104506

→
Entity typeother

Related Parties

1
  • filerCIK 0001796960

Filing Metadata

Form type
4
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 4:06 PM ET
Size
28.7 KB
View on SEC.gov